Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chul Ahn

Showing results (531-540 of 539) with videos related to

Pageof 54
Sort By:
You have reached the last page of results.This site can display upto 539 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2021
Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell CarcinomaRaquibul Hannan, Osama Mohamad, Alberto Diaz de Leon, et al.
Nature Communications|December 27, 2024
A conserved pilin from uncultured gut bacterial clade TANB77 enhances cancer immunotherapyChan Yeong Kim, Dong Jin Park, Beung Chul Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2020
Concentration-dependent Early Antivascular and Antitumor Effects of Itraconazole in Non-Small Cell Lung CancerDavid E Gerber, William C Putnam, Farjana J Fattah, et al.
Nature Genetics|November 13, 2007
Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissectionsDong-Chuan Guo, Hariyadarshi Pannu, Van Tran-Fadulu, et al.
European Journal of Cancer (Oxford, England : 1990)|June 28, 2021
Clinical decision support algorithm based on machine learning to assess the clinical response to anti-programmed death-1 therapy in patients with non-small-cell lung cancerBeung-Chul Ahn, Jea-Woo So, Chun-Bong Synn, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 28, 2026
Consensus statement on ctDNA minimal residual disease (MRD) testing in early-stage NSCLC - A Delphi study by the Asian Thoracic Oncology Research Group (ATORG)Aaron C Tan, Bin-Chi Liao, Molly Li, et al.
Frontiers in Oncology|March 31, 2022
Incorporation of SKI-G-801, a Novel AXL Inhibitor, With Anti-PD-1 Plus Chemotherapy Improves Anti-Tumor Activity and Survival by Enhancing T Cell ImmunityWongeun Lee, Dong Kwon Kim, Chun-Bong Synn, et al.
Clinical & Translational Immunology|January 10, 2022
SKI-G-801, an AXL kinase inhibitor, blocks metastasis through inducing anti-tumor immune responses and potentiates anti-PD-1 therapy in mouse cancer modelsChun-Bong Synn, Sung Eun Kim, Hee Kyu Lee, et al.
Science (New York, N.Y.)|March 9, 2023
Protein-metabolite interactomics of carbohydrate metabolism reveal regulation of lactate dehydrogenaseKevin G Hicks, Ahmad A Cluntun, Heidi L Schubert, et al.
Pageof 54

Showing results (531-540 of 539) with videos related to

Sort By:
Pageof 54
You have reached the last page of results.This site can display upto 539 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2021
Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell CarcinomaRaquibul Hannan, Osama Mohamad, Alberto Diaz de Leon, et al.
Nature Communications|December 27, 2024
A conserved pilin from uncultured gut bacterial clade TANB77 enhances cancer immunotherapyChan Yeong Kim, Dong Jin Park, Beung Chul Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2020
Concentration-dependent Early Antivascular and Antitumor Effects of Itraconazole in Non-Small Cell Lung CancerDavid E Gerber, William C Putnam, Farjana J Fattah, et al.
Nature Genetics|November 13, 2007
Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissectionsDong-Chuan Guo, Hariyadarshi Pannu, Van Tran-Fadulu, et al.
European Journal of Cancer (Oxford, England : 1990)|June 28, 2021
Clinical decision support algorithm based on machine learning to assess the clinical response to anti-programmed death-1 therapy in patients with non-small-cell lung cancerBeung-Chul Ahn, Jea-Woo So, Chun-Bong Synn, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 28, 2026
Consensus statement on ctDNA minimal residual disease (MRD) testing in early-stage NSCLC - A Delphi study by the Asian Thoracic Oncology Research Group (ATORG)Aaron C Tan, Bin-Chi Liao, Molly Li, et al.
Frontiers in Oncology|March 31, 2022
Incorporation of SKI-G-801, a Novel AXL Inhibitor, With Anti-PD-1 Plus Chemotherapy Improves Anti-Tumor Activity and Survival by Enhancing T Cell ImmunityWongeun Lee, Dong Kwon Kim, Chun-Bong Synn, et al.
Clinical & Translational Immunology|January 10, 2022
SKI-G-801, an AXL kinase inhibitor, blocks metastasis through inducing anti-tumor immune responses and potentiates anti-PD-1 therapy in mouse cancer modelsChun-Bong Synn, Sung Eun Kim, Hee Kyu Lee, et al.
Science (New York, N.Y.)|March 9, 2023
Protein-metabolite interactomics of carbohydrate metabolism reveal regulation of lactate dehydrogenaseKevin G Hicks, Ahmad A Cluntun, Heidi L Schubert, et al.
Pageof 54